[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100638484":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":23,"studyPopulation":13,"armGroups":24,"interventions":35,"overallOfficials":13,"centralContacts":41,"locations":13,"responsibleParty":47,"collaborators":13,"id":51,"slug":13,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":13,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":13,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":13,"overallStatus":69,"whyStopped":13,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":13},{"fullName":5,"class":6},"Ain Shams University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"FLACC pain scale (face,leg , activity,cry, consolability) in the first 24 hours postoperative","Assessment for additive analgesic effects of caudal Dexamethasone","6 months",null,{"allocation":15,"interventionModel":16,"interventionModelDescription":13,"primaryPurpose":17,"observationalModel":13,"timePerspective":13,"maskingInfo":18},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":19,"maskingDescription":13,"whoMasked":20},"DOUBLE",[21,22],"INVESTIGATOR","OUTCOMES_ASSESSOR","Evaluate the additive analgesic effects of caudal Dexamethasone in neonates undergoing inguinal hernia repair.\n\nadditive side effects if found",[25,31],{"label":26,"type":27,"description":28,"interventionNames":29},"Dexamethasone - Bupivacaine group","ACTIVE_COMPARATOR","Add Dexamethasone to Bupivacaine in caudal anesthesia in neonate",[30],"Procedure: We add Dexamethasone to Bupivacaine as adjuvant to Bupivacaine in neonsates undergoing inguinal hernia repair in Dexamethasone - Bupivacaine group",{"label":32,"type":6,"description":33,"interventionNames":34},"Saline - Bupivacaine group","Control group to the other arm of the study",[30],[36],{"type":37,"name":38,"description":39,"armGroupLabels":40,"otherNames":13},"PROCEDURE","We add Dexamethasone to Bupivacaine as adjuvant to Bupivacaine in neonsates undergoing inguinal hernia repair in Dexamethasone - Bupivacaine group","We add Dexamethasone to Bupivacaine as adjuvant to Bupivacaine in neonates undergoing inguinal hernia repair",[26,32],[42],{"name":43,"role":44,"phone":45,"phoneExt":13,"email":46},"Sawsan Haridy Ahmed Abu El Hassan, Lecturer of anesthesia","CONTACT","002- 01228118341","sawsan_haridy@med.asu.edu.eg",{"type":48,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":13,"oldOrganization":13},"PRINCIPAL_INVESTIGATOR","sawsan haridy ahmed aboelhassan","Lecturer and Consultant of Anesthesiology in Ain Shams University.","100638484",false,"NCT07609836","Caudal Dexamethasone - Bupivacaine in Neonates","Analgesic Efficacy Of Dexamethasone As Adjuvant To Caudal Bupivacaine For Neonates Undergoing Inguinal Hernia Repair: Randomized Controlled Study","Inclusion Criteria:\n\n* full term neonate\n* ASA I \\& ASA II\n* Scheduled for inguinal hernia repair\n\nExclusion Criteria:\n\n* Patients with allergies to studied drugs\n* body weight \\\u003C3 kilograms\n* parents refusal","ALL","1 Day","28 Days",{"count":61,"type":62},150,"ESTIMATED","INTERVENTIONAL",[65],"NA","Randomied controlled study Evaluate the effects of caudal Dexamethasone in neonates",[68],"We Are Studying the Effects of Caudal Dexamethasone in Neonates Undergoing Inguinal Hernia Repair","NOT_YET_RECRUITING","2026-05-20",{"date":72,"type":73},"2026-05-27","ACTUAL",{"date":75,"type":62},"2026-05",{"date":77,"type":62},"2026-12",{"name":5,"class":6}]